Chris Lee
Vice President, China Asset Management (Hong Kong) Limited
Gain timely investment insights on:
By subscribing, you agree to receive research insights and marketing communications from us. You may unsubscribe at any time. See our Privacy Policy for details.
In mid-June, a compelling market divergence emerged: as semiconductors pulled back sharply, Hong Kong’s biotech sector staged a powerful rally. What triggered this rebound? Why are individual stock performances diverging? Which biotech names is China Asset Management (Hong Kong) selectively overweighting?
In this webinar, we have invited Mr. Chris Lee, Vice President of China Asset Management (Hong Kong), to provide an in-depth analysis on:
•Biotech: Unpacking the drivers behind June's biotech surge during the semiconductor dip, analyzing stock divergence, and highlighting ChinaAMC's top biotech stock picks.
•High-Dividend Strategies: Targeting ~8% dividend yield plus potential capital appreciation across commodity cycles, Asian REITs, and toll roads, alongside an analysis of ETF income drivers.
•Money Market Funds: Ideal for steady passive income, sharing the latest yields and portfolio holdings for HKD and USD money market funds.
Register now! Join our expert to explore how to balance growth and defense in volatile markets.
Seminar Details:
Date: 17 September, 2026 (Thursday)
Time: 6:30pm – 7:30pm
Location: Online
Language: Cantonese
Vice President, China Asset Management (Hong Kong) Limited